Journal Buah Ketapang (Ficus Lyrata)
Journal Buah Ketapang (Ficus Lyrata)
Journal Buah Ketapang (Ficus Lyrata)
Abstract. In this study, the antimicrobial activity of ethyl acetate latex extract of Ficus lyrata L. and
Nystatin on 65 clinical isolates of Candida albicans from Vulvovaginal candidiasis and standard strain of
C.albicans ATCC 5027 were studied. The plant extract was obtained from Iranian commercial company.
Inhibitory effects of the crude extract analyzed by using the disk diffusion technique (Bauer et al., 1966). The
obtained results showed that Ficus lyrata L. extract has inhibitory effect on clinical isolates and type strain of
C.albicans in lower concentrations than Nystatin drug with the diameters of inhibition zones ranging from 22
to 26 mm and 30 to 32 for clinical isolates and standard strains of C.albicans, respectively. The diameter of
inhibition zones for Nystatin was between 16 to 20 mm and 21 to 24 mm for standard strain and clinical
isolates of C.albicans, respectively. Based on the data analysis (Macro dilution broth method), the best MIC
of Ficus lyrata L. ethyl acetate latex extract on clinical isolates and type strain of C.albicans were 25 mg/ml
and 2.5 mg/ml, respectively. The best MIC of Nystatin on clinical isolates and type strain of C.albicans were
36 mg/ml but MIC of combination of both showed more potency than Nystatin alone (0.05mg/ml), which is a
synergistic effect. The GC/MS analysis of latex showed that extract contains alkaloids, flavonoids, phenols,
Tannins, terpenoid. The present study forms the basis for further investigations to isolate active components,
elucidated the structures and evaluates them against wider range of microbial strains with the goal to find
new the therapeutic principles.
Keywords: Ficus lyrata, Candida albicans, Nystatin, Latex extract
1. Introduction
Todays use of medicinal plants and bioactive phytocompounds worldwide and our scientific knowledge
of them comprise the modern field of the phytosciences. The phytosciences have been created from the
integration of disciplines that have never been linked before, combining diverse areas of economic, social,
and political fields, chemistry, biochemistry, physiology, microbiology, medicine, and agriculture. The field
is unique among the biomedical sciences in that instead of testing a hypothesis, in the phytosciences
researchers try to determine whether plants commonly used in traditional medicine brings benefits for health
and, if so, what their mechanisms of action are. Despite the common belief that phytocompounds are safe,
they all have inherent risks just like synthetic compounds. Thus it is within the scope of the phytosciences to
elucidate side-effects, appropriate doses, identify bioactive phytocompounds and ways of extraction and
conservation. Besides these, legal aspects regarding regulation of the prescription and commercial sale of
medicinal plants are a matter of debate all around the world. The varied regulations in different jurisdictions
regarding the prescription and sale of these products add confusion to the formal use of phytocompounds.
Several phytochemical surveys have been published, including the random sampling approach which
involved some plant accessions collected from all parts of the world. The major chemical substances of
interest in these surveys have been the alkaloids and saponins, however, other diverse groups of naturally
occurring Phytochemicals such as flavonoids, tannins, unsaturated sterols, triterpenoids, essential oils, etc.
have also been reported. Our approach involved the collection, identification, extraction and phytochemical
115
evaluation of extracts derived primarily from a random selection of commonly occurring native plants. Aim
of this research was preliminary phytochemical screening, bioactivity determination and finally MIC of ethyl
acetate latex extract obtained from Ficus lyrata Linn. against standard strain and clinical isolates of Candida
albicans. Analysis was performed using agar disk diffusion and the broth macrodilution assay respectively.
2. Botany
Ficus lyrata L. belongs to family Moracea. Ficus lyrata Linn. (Syn: Ficus sycomorous; family:
Moraceae) is commonly referred as Fig . A small or moderate sized deciduous tree, 15-30 ft high with
broad ovate or nearly orbicular leaves, more or less deeply 3-5 lobed, rough above and pubescent below;
fruits axillary, usually peer shaped, variable in size and color. The fig plant is considered to be a native of
carica in Asia and is grown in nearly all tropical and sub-tropical Countries. It is now cultivated chiefly in
the Mediterranean region, from Turkey in the east to Spain and Portugal in the west; it is also grown
commercially in parts of U.S.A. and Chile and, to a small extent, in India, Arabia, China and Japan(13). Its
fruit, root and leaves are used in the native system of medicine in Different disorders such as gastrointestinal
(colic, indigestion, loss of appetite and diarrhea), respiratory (sore throats, coughs and bronchial problems),
inflammatory and cardiovascular disorders. Fig has been traditionally used for its medicinal benefits as
metabolic, cardiovascular, respiratory, antispasmodic and anti-inflammatory remedy. F. lyrata has been
reported to have numerous bioactive compounds such as arabinose, -amyrins, -carotenes, glycosides, setosterols and xanthotoxol (2, 7, and 12).Preliminary identification of the plant was done in the field by a
botanist. Herbarium specimens were prepared and photographs were taken to aid in the confirmation of the
identity of the plant. Voucher specimens were deposited in the Herbarium of the botany department, Islamic
Azad University of Lahijan, where identity of the plants was confirmed by comparison with available
voucher specimens.
5. Organisms
Standard strain of Candida albicans (ATCC 5027) obtained from ATCC, Fairfax, VA, USA, was grown
and maintained on SDA agar slants.
6. Inoculum
Saboraud dextrose agar (SDA; Biotec Laboratories Ltd.UK) was used to prepare the culture medium
according to the manufacturer's directions. Candida albicans ATCC5027 (provided by IROST organization
in Iran) was aseptically inoculated on petridishes containing autoclaved, cooled and settled medium. The
petridishes were incubated at 31C for 48 h to give white round colonies against a yellowish background.
These were aseptically sub-cultured on SDA slants Candida albicans colonies from SDA slants were
suspended in sterilized 0.9% sodium chloride solution (normal saline), which was compared with 0. 5
McFarland solution. The microbial suspension (1 ml) in normal saline was added to 74 ml of sterile medium,
kept at 45C, to give concentration of 2 107 cells/ml.
116
117
Organism
extract
Saponins
Alkaloids
++
Phenolics
++
Tannins
Terpenoids
+
-
Amino acids
Flavonoids
++
Nystatin
Crude Extract
28
16-20
28
20-24
(mm)
C.albicans
(standard strain)
C.albicans
(clinical isolate)
Table 3. Anti-Candida activity (MIC) of Ficus lyrata L. Ethyl acetate latex extract (mg/ml)
Determination of MIC
Nystatin
Extract
C.albicans
0.05mg/ml
0.05mg/ml
0.5mg/ml
0.5mg/ml
25mg/ml
2.5mg/ml
(St.strain&Isolate)
C.albicans
(Clinical isolate)
C.albicans
(Standard strain)
9. References
[1] Ahmad L. and Beg AZ. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multidrug
resistant human pathogens. Journal of Ethno pharmacology, 74 (2001): 113-123.
[2] Jeong, W.S., Lachance, P.A., Phytosterols and fatty acids in fig (Ficus lyrata, var. Mission) fruit and tree
components. Food Chemistry and Toxicology; 66 (2001): 278281.
[3] Houda lazareg arefi. et al. In vitro antimicrobial activity of four Ficus carica latex fractions against resistant human
pathogens (antimicrobial activity of Ficus lyrata latex). Pak.J.Pharm.Sci, Vol.23, No.1, January 2010.pp.53-58.
118
[4] Kslev ME, Hartmann A and Bar-Yosefo. Early domesticated fig in the Jordan Valley. Science, 312 (2006): 13721374.
[5] Kuo, Y.H., Li, Y.C. Constituents of the bark of Ficus microcarpa L. Journal of Chinese Chemical. Society 44
(1997): 321325.
[6] Mandal, S.C., Saha, B.P., Pal, M. Study on antibacterial activity of Ficus racemosa Lunn. Leaf extract.
Phytotherapy Research 14(2000): 278280.
[7] McGovern TW. The fig-Ficus carica L. Cutis; 69 (2002):339-40.
[8] Prez C, Canal JR, Torres MD. Experimental diabetes treated with Ficus lyrata extract: effect on oxidative stress
parameters. Acta Diabetol; 40 (2003):3-8.
[9] Solomon, A., Golubowicz, S., Yablowicz, Z.,Grossman, S., Bergman, M., Gottlieb, H.E., Altman, A., Kerem, Z.,
Flaishman, M.A., Antioxidant activities and anthocyanin content of fresh fruits of common fig (Ficus carica L.).
Journal of Agricultural and Food Chemistry; 54(2006):77177723.
[10] Salie, F., Eagles, P.F.K., Leng, H.M.J. Preliminary antimicrobial screening of four South African Asteraceae
species. Journal of Ethnopharmacology 52 (1996): 2733.
[11] Sarang B, Anpurna K, Beenish K, Sheikh FA, Suri KA, Satti NK, Musarat A and Qazi, GN. Immunosuppressive
properties of an ethyl acetate fraction from Euphorbia royleana. Journal of Ethnopharmacology, 99 (2005): 185-192.
[12] Vaya J, Mahmood S. Flavonoid content in leaf extracts of the fig (Ficus lyrata L.), carob (Ceratonia siliqua L.) and
pistachio (Pistacia lentiscus L.). Biofactors; 28 (2006):169-75.
[13] V. Kuetea,d,B., Ngamenib, C.C. Fotso Simoc, R. Kengap Tankeuc, B. Tchaleu Ngadjuib,c, J.J.M. Meyer d, N.Lall
d, J.R.Kuiatea. Journal of Ethnopharmacology 120 (2008): 1724.
[14] Vogel HG, editor. Drug Discovery and Evaluation Pharmacological Assays 2nd Ed. New York: Springer-Verlager
Berlin Heidelberg ;( 2002); 696-7,692.
[15] Wakeel, O.K., Aziba, P.I., Ashorobi, R.B., Umukoro, S., Aderibigbe, A.O., Awe, E.O. Neuropharmcological
activities of Ficus platyphylla stem bark in mice. African Journal of Biomedical Research 7(2004): 7578.
[16] Wang L, Jiang W, Ma K, Liang Z and Wang Y.The production and research of fig (Ficus lyrata L.) in china. Acta
Horticulture, 605 (2003): 191-196.
[17] Zgoda, J.R., Porter, J.R. A Convenient microdilution method screening natural products against bacteria and fungi.
Pharmaceutical Biology 39 ( 2001) : 221225.
119